Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples